Next generation of popular skincare solutions combine anti-aging and brightening agents to help reduce the appearance of wrinkles, fine lines, pores and discoloration for normal and sensitive skin types
EMERYVILLE, Calif., May 09, 2022–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces the expansion of its top-selling Kakadu C and Calm Cool + Corrected product lines with the introduction of next-generation products that are uniquely formulated with anti-aging ingredients to help reduce the appearance of wrinkles, fine lines, pores and discoloration.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220509005104/en/
DERMAdoctor Calm Cool + Corrected Bakuchiol Retinol Alternative Serum (Photo: Business Wire)
Kakadu C with 1% Retinol + 12% C Ferulic & E Complex combines high-potency retinol to resurface and exfoliate skin with vitamin C, ferulic acid and vitamin E to fight free radical damage into a sophisticated, highly effective hydrating emulsion. Kakadu C with 1% Retinol + 12% C Ferulic & E Complex is recommended to be applied sparingly with initial use of not more than every other night.
Calm Cool + Corrected Bakuchiol Retinol Alternative Serum features high-performance bakuchiol, a natural alternative to retinol that delivers the powerful anti-aging benefits of increased cellular turnover and collagen production, but is gentle enough for sensitive skin. Mega-moisturizing polyglutamic acid, radiance-boosting vitamin B12 and natural AHAs for gentle exfoliation are added together with botanicals into a luxe serum with skin-soothing and calming benefits. Calm Cool + Corrected Bakuchiol Retinol Alternative Serum is recommended for application once daily.
“We’ve expanded two highly popular skincare collections that our customers love and trust with next-generation anti-aging formulas to revitalize skin for a brighter, more youthful appearance,” said Audrey Kunin, M.D., NovaBay’s Chief Product Officer and a board-certified dermatologist. “Our Kakadu C 1% Retinol with 12% Vitamin C Ferulic Acid and E Complex is a truly unique, clinically concentrated power coupling of ingredients creating a first of its kind cutting-edge, anti-aging complex. Our use of the Kakadu plum, believed to be the world’s most concentrated natural source of Vitamin C, takes this unique formulation to another level.
“While retinol is a well-recognized go-to rejuvenating ingredient among dermatologists, not everyone can tolerate its use. This is especially true for sensitive skin and among those prone to eczema or rosacea,” Dr. Kunin added. “I believe everyone deserves the benefits of retinol, which is why we have also introduced our Calm Cool + Corrected Bakuchiol Retinol Alternative Serum. Bakuchiol is a plant-derived natural ingredient that provides the benefits of retinol without the downside of irritation, making it ideal for those with challenging skin who desire effective anti-aging products.
“Importantly, our newest formulations deliver on the DERMAdoctor promise that clinical skin therapy can be fun and easy for all while producing significant, visible results. Our skincare solutions combine science, innovation and creativity and our formulas mix compassion with expertise to ensure that when it comes to skin, no age group, gender, race or person is left out,” she concluded.
Kakadu C with 1% Retinol + 12% C Ferulic & E Complex is available in a 30 ml size for $75 and Calm Cool + Corrected Bakuchiol Retinol Alternative Serum is available in a 30 ml size for $58 at Amazon.com. Both products are available at dermadoctor.com, which also offers monthly auto delivery at a 15% discount along with free shipping.
The Kakadu C product family features the skin indulging benefit of the Kakadu plum, one of the richest natural vitamin C sources known on earth, harvested in a remote Australian territory. Ounce per ounce, Kakadu plums contain on average 55 times more vitamin C than Florida oranges and help protect skin against pollutants, oxidative stress and free radical damage.
Calm Cool + Corrected Bakuchiol Retinol Alternative Serum joins the recently launched Hydrating Cleansing Oil and Moisture Recover HA Serum as the newest addition to DERMAdoctor’s Calm Cool + Corrected collection. This collection is designed to help soothe and comfort skin that’s prone to irritation, including those with eczema or rosacea.
All DERMAdoctor products are clean, allergy-tested and hypoallergenic, free of synthetic dyes and cruelty-free with no animal testing.
About NovaBay Pharmaceuticals, Inc:
NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells scientifically created and clinically proven consumer products for the eyecare and skincare markets. Avenova® is the most prescribed antimicrobial lid and lash spray and DERMAdoctor is a premium skincare brand offering more than 30 dermatologist-developed skincare products sold through traditional domestic retailers, digital beauty channels and international distributors.
NovaBay Pharmaceuticals Forward-Looking Statements
Except for historical information herein, matters set forth in this press release may be forward looking within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including statements about the commercial progress and future financial performance of NovaBay Pharmaceuticals, Inc. This release contains forward-looking statements that are based upon management’s current expectations, assumptions, estimates, projections and beliefs. These statements include, but are not limited to, statements regarding our business strategies, current product offerings, marketing efforts, and any future revenue that may result from selling such products, as well as generally the Company’s expected future financial results. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or achievements to be materially different and adverse from those expressed in or implied by the forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, risks and uncertainties relating to the size of the potential market for our products, the integration of DERMAdoctor’s business into the Company’s business, the possibility that the available market for the Company’s products will not be as large as expected, the Company’s products will not be able to penetrate one or more targeted markets, and revenues will not be sufficient to meet the Company’s cash needs. Other risks relating to NovaBay’s business, including risks that could cause results to differ materially from those projected in the forward-looking statements in this press release, are detailed in NovaBay’s latest Form 10-Q/K filings and Registration Statement on Form S-1 filing with the Securities and Exchange Commission, especially under the heading “Risk Factors.” The forward-looking statements in this release speak only as of this date, and NovaBay disclaims any intent or obligation to revise or update publicly any forward-looking statement except as required by law.
Socialize and Stay Informed on NovaBay’s Progress
Avenova Purchasing Information
DERMAdoctor Purchasing Information
View source version on businesswire.com: https://www.businesswire.com/news/home/20220509005104/en/
Chief Executive Officer and General Counsel
LHA Investor Relations